Page last updated: 2024-08-23

tobramycin and cefotaxime

tobramycin has been researched along with cefotaxime in 129 studies

Research

Studies (129)

TimeframeStudies, this research(%)All Research%
pre-199057 (44.19)18.7374
1990's21 (16.28)18.2507
2000's35 (27.13)29.6817
2010's14 (10.85)24.3611
2020's2 (1.55)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A1
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A1
Courvalin, P; Galimand, M; Périchon, B1
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R1
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y1
Adams-Haduch, JM; Doi, Y; Paterson, DL1
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z1
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K1
Lombardo, F; Obach, RS; Waters, NJ1
Espedido, BA; Iredell, JR; Partridge, SR1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Bauernfeind, A; Keuleyan, E; Markovska, R; Queenan, AM; Rasshofer, R; Schneider, I1
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL1
Cattoir, V; Nordmann, P; Poirel, L1
Berçot, B; Nordmann, P; Poirel, L1
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N1
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C1
Bradford, PA; Jones, CH; Keeney, D; Ruzin, A; Tuckman, M1
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD1
Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A1
Gales, AC; Nordmann, P; Picão, RC; Poirel, L1
Choi, SH; Jeong, JY; Jun, JB; Kim, ES; Kim, MN; Kim, YS; Lee, SO; Woo, JH1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N1
Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E1
Courvalin, P; Coyne, S; Guigon, G; Périchon, B1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP1
Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Maravić, A; Odžak, R; Skočibušić, M1
Kallfelz, HC; Oppermann-Paul, K; Paul, T; Peltner, HU1
Bryant, RE; Fox, K; Morthland, VH; Oh, G1
Armstrong, P; Blair, P; Lowry, K; Rowlands, BJ; Smilie, J; Webb, H1
Maiche, AG; Teerenhovi, L1
Francom, S; Jaimovich, DG; Kumar, A1
Ahnefeld, FW; Deller, A; Graf, B; Heeg, K; Kilian, J; Konrad, F1
Allington, DR; Chandler, MH; Pennell, AT1
Gamillscheg, A; Hauer, C; Lackner, H; Slavc, I; Urban, C1
Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H1
Chastagner, P; Flamant, F; Hartmann, O; Kalifa, C; Lemerle, J; Patte, C; Tancrede, C1
Almirall, J; Montoliu, J; Ponz, E; Revert, L1
Ahnefeld, FW; Heeg, K; Kilian, J; Konrad, F; Schwalbe, B; Wagner, H; Wiedeck, H1
Alcock, SR; Parrott, DM; Speekenbrink, AB1
Grzeszczak, W; Kokot, F; Wiecek, A1
Banzer, S; Mondorf, A; Mondorf, W1
Broustet, A; Fourche, J; Leng, B; Marit, G; Pellegrin, JL; Reiffers, J; Texier-Maugein, J1
Weinstein, MP1
Bergeron, MG; Charest, A; Forcier, JF; LeBel, M; Morin, J; Vallée, F1
Holloway, JJ; Lietman, PS; Moore, RD; Smith, CR1
Hulstaert, PF; Kerver, AJ; Mevissen-Verhage, EA; Rommes, JH; Verhoef, J; Vos, A; Wittebol, P1
Adams, KR; Cierny, G; Mader, JT; Wilson, KJ1
Ardilouze, JL; Arich, C; Bengler, C; Dubois, A; Fabre, S; Gouby, A; Hansel, S; Janbon, C; Joubert, P1
Brunet, F; Dhainaut, JF; Dreyfus, F; Huyghebaert, MF; Lanore, JJ; Monsallier, JF; Varet, B1
Stoutenbeek, CP; van Saene, HK; Zandstra, DF1
Husson, MO; Izard, D; Leclerc, H2
Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J1
Chin, NX; Labthavikul, P; Neu, HC1
Lietman, PS; Moore, RD; Smith, CR2
Chin, NX; Labthavikul, P; Neu, HC; Saha, G1
Andrzejowska, H; Grzeszczak, W; Kokot, F; Wiecek, A1
Betzler, M; Geisen, HP; Schipplick, M; Schömig-Breckner, J1
Langrehr, D; Miranda, DR; Stoutenbeek, CP; van Saene, HK; Zandstra, DF1
Grassi, C1
Berk, SL1
Feshchenko, IuI; Molotkov, VN1
Bakken, JS; Hulsund, M1
Ali, RM; Beeching, NJ; Lang, SD; Shaw, DW1
Ambinder, R; Israel, E; Levitt, R; Lietman, PS; Lipsky, JJ; Longstreth, J; Mellits, ED; Petty, BG; Rocco, L; Smith, CR1
Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P1
Béland, L; Biron, S; Bourque, RA; Brochu, G; Marceau, P; Piché, P; Potvin, M1
Rahman, M1
Grötsch, H; Kuhlmann, J; Seidel, G1
Knothe, H1
Shah, PM; Stille, W; Troche, G1
Murray, PR1
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ1
Daschner, FD; Schneider, H; Steffens, A1
Klastersky, J; Lagast, H; Zinner, SH1
Drew, WL; Mintz, L1
Fass, RJ1
Bailey, D; Feld, R; Fong, I; Harding, G; Mandell, L; Rachlis, A; Vincelette, J1
Neu, HC1
Canawati, HN; Gilmore, DS; Jiminez, EM; Malik, GM; Montgomerie, JZ; Morrow, JW1
Duma, RJ1
Ashley, MA; Kim, C; Montgomerie, JZ; Schick, DG1
Baer, DM; Horner, W; Jones, RN; Mullooly, JP1
Asphaug Kjellevold, V; Dibb, WL; Digranes, A1
Watanakunakorn, C1
Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC1
Angehrn, P1
Miranda, DR; Stoutenbeek, CP; Van Saene, HK; Zandstra, DF1
Cobbs, CG; Elliott, AM; Karam, GH1
Pohlod, DJ; Saravolatz, LD1
Brandis, M; Burghard, R; Gordjani, N; Leititis, JU; Mathäi, H; Mergehenn, G; Müller, D1
Fernández-del Castillo, C; Ferraro, MJ; Foitzik, T; Mithöfer, K; Rattner, DW; Warshaw, AL1
Hammond, JM; Potgieter, PD2
Carson, M; Hellyar, A1
Eckel, HE; Lippert, KL; Merz, E; Schmitt, HJ; Schönberger, W; Zorowka, P1
Bion, JF; Crosby, HA; Elliott, TS; Penn, CW1
Enríquez, A; González-Lahoz, J; Guinea, J; Valencia, ME1
Alestig, K; Eilard, T; Ek, E; Hebelka, M; Johansson, E; Olinder-Nielsen, AM; Sandberg, T1
Exner, H; Finke, U; Joosten, U; Schardey, HM; Schauer, R; Schildberg, FW; Staubach, KH1
Caron, F1
Hubbard, RW; Slocum, R1
Rommes, JH; van Saene, HK; Zandstra, DF1
Geraedts, AA; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF1
Laynez, P; Martínez, A; Miguélez, M; Romero, R1
Bethe, U; Cornely, OA; Diehl, V; Fätkenheuer, G; Franzen, C; Hartmann, P; Salzberger, B; Schrappe, M; Seifert, H; Steinmetz, T1
van den Anker, JN1
Aquino, VM; Scothorn, DJ; Timmons, CF; Winick, NJ1
de la Cal, MA; Kolak, J; Peric, M; Silvestre, L; van Saene, HK1
Doi, M; Hayashi, M; Murakami, T; Nakashima, K; Nakayasu, H; Sawada, H1
Aschoff, R; Baldauf, A; Leike, S; Meurer, M; Wirth, MP1
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H1
Bonten, MJ; de Smet, AM; Kluytmans, JA; Melsen, WG1
Franz, C; Gerber, A; Mainz, JG1
Bonten, MJ; de Smet, AM; Oostdijk, EA1
Bovyn, T; Dobbelaere, A; Ide, L; Jeannin, P1
Kostrzewa, M; Schubert, S; Sparbier, K1
Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C1
Barsuk, AL; Lovtsova, LV; Nekaeva, ES; Urakov, AL1
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I1

Reviews

5 review(s) available for tobramycin and cefotaxime

ArticleYear
Respiratory infections: clinical evaluation.
    Clinical therapeutics, 1985, Volume: 7 Suppl A

    Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin

1985
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 1998, Volume: 8, Issue:6

    Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections

1998
[Selective decontamination of the digestive tract reduces mortality in intensive care patients].
    Nederlands tijdschrift voor geneeskunde, 1999, Mar-20, Volume: 143, Issue:12

    Topics: Amphotericin B; Bacterial Infections; Cefotaxime; Clinical Protocols; Colistin; Critical Care; Critical Illness; Cross Infection; Decontamination; Digestive System; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Survival Rate; Tobramycin

1999
Control of bacterial pneumonia during mechanical ventilation.
    Croatian medical journal, 2005, Volume: 46, Issue:2

    Topics: Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Chemoprevention; Cross Infection; Equipment Contamination; Humans; Hygiene; Intensive Care Units; Length of Stay; Pneumonia, Bacterial; Polymyxin B; Respiration, Artificial; Tobramycin

2005
Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).
    Sovremennye tekhnologii v meditsine, 2021, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; Cefotaxime; Decontamination; Drug Resistance, Microbial; Humans; Tobramycin

2021

Trials

25 trial(s) available for tobramycin and cefotaxime

ArticleYear
Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit.
    Surgery, 1991, Volume: 110, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Bacterial Infections; Cefotaxime; Cost-Benefit Analysis; Critical Care; Cross Infection; Digestive System; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Polymyxins; Prospective Studies; Tobramycin

1991
Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
    Infection, 1991, Volume: 19 Suppl 6

    Topics: Administration, Oral; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Ofloxacin; Tobramycin

1991
[Pneumonia prevention in long-term mechanically ventilated patients: selective skin decontamination according to Stoutenbeek or prevention of colonization according to Unertl? A prospective randomized comparison of both treatments].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 1991, Volume: 26, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Female; Gentamicins; Humans; Male; Middle Aged; Pneumonia; Polymyxin B; Prospective Studies; Respiration, Artificial; Time Factors; Tobramycin

1991
A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Aminopeptidases; Biomarkers; CD13 Antigens; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Kidney; Multicenter Studies as Topic; Tobramycin

1987
[Randomized prospective study of ceftazidime versus a cefotaxime-tobramycin combination in acute leukemia in therapeutic aplasia].
    Presse medicale (Paris, France : 1983), 1988, Oct-26, Volume: 17, Issue:37

    Topics: Adolescent; Adult; Cefotaxime; Ceftazidime; Drug Therapy, Combination; Female; Humans; Infection Control; Leukemia; Male; Prospective Studies; Random Allocation; Remission Induction; Tobramycin

1988
Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Archives of internal medicine, 1986, Volume: 146, Issue:6

    Topics: Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Fees and Charges; Humans; Kidney; Maryland; Nafcillin; Random Allocation; Regression Analysis; Time Factors; Tobramycin

1986
Prevention of colonization and infection in critically ill patients: a prospective randomized study.
    Critical care medicine, 1988, Volume: 16, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Child; Colistin; Cross Infection; Digestive System; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Oropharynx; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory System; Tobramycin

1988
[Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Pathologie-biologie, 1987, Volume: 35, Issue:5

    Topics: Aged; Cefazolin; Cefotaxime; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Middle Aged; Prospective Studies; Random Allocation; Sepsis; Tobramycin

1987
Studies of risk factors for aminoglycoside nephrotoxicity.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 8, Issue:5

    Topics: Acute Kidney Injury; Age Factors; Aminoglycosides; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Diseases; Nafcillin; Probability; Risk; Time Factors; Tobramycin

1986
[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1986, Sep-29, Volume: 41, Issue:39

    Topics: Adult; Cefotaxime; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Tobramycin; Urinary Tract Infections

1986
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
    The American journal of medicine, 1986, Volume: 80, Issue:6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Double-Blind Method; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Nafcillin; Tobramycin

1986
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infusions, Parenteral; Kidney Diseases; Male; Middle Aged; Nafcillin; Penicillin Resistance; Prognosis; Pseudomonas Infections; Random Allocation; Tobramycin; Urinary Tract Infections

1984
Short-term antibiotherapy for peritonitis: prospective, randomized trial comparing cefotaxime-metronidazole and clindamycin-tobramycin.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl B

    Topics: Cefotaxime; Clindamycin; Clinical Trials as Topic; Diverticulitis; Drug Combinations; Humans; Metronidazole; Peritonitis; Prospective Studies; Random Allocation; Tobramycin

1984
Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.
    Infection, 1982, Volume: 10, Issue:4

    Topics: Adolescent; Adult; Aged; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Cefotaxime; Creatinine; Drug Therapy, Combination; Female; Humans; Kidney; Male; Middle Aged; Tobramycin

1982
A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftizoxime; Clindamycin; Drug Therapy, Combination; Humans; Pelvis; Tobramycin

1982
Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Ceftizoxime; Female; Humans; Male; Middle Aged; Recurrence; Spinal Cord Injuries; Tobramycin; Urinary Tract Infections

1982
Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
    Pediatric nephrology (Berlin, Germany), 1995, Volume: 9, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta 2-Microglobulin; Biomarkers; Cefotaxime; Cephalosporins; Creatinine; Dipeptidyl Peptidase 4; Humans; Infant, Newborn; Prospective Studies; Tobramycin

1995
Long-term effects of selective decontamination on antimicrobial resistance.
    Critical care medicine, 1995, Volume: 23, Issue:4

    Topics: Adult; Amphotericin B; APACHE; Bacteria; Cefotaxime; Colistin; Cross Infection; Digestive System; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Prospective Studies; Respiration, Artificial; Tobramycin

1995
Is there a role for selective decontamination of the digestive tract in primarily infected patients in the ICU?
    Anaesthesia and intensive care, 1995, Volume: 23, Issue:2

    Topics: Administration, Oral; Adult; Amphotericin B; Cefotaxime; Colistin; Critical Care; Critical Illness; Cross Infection; Digestive System; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Placebos; Prospective Studies; Respiration, Artificial; Survival Rate; Tobramycin

1995
Serial measurements of transient evoked otoacoustic emissions (TEOAEs) in healthy newborns and in newborns with perinatal infection.
    International journal of pediatric otorhinolaryngology, 1993, Volume: 27, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Auditory Perception; Bacterial Infections; Cefotaxime; Cochlea; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Infant, Newborn; Male; Netilmicin; Reflex, Acoustic; Reproducibility of Results; Tobramycin

1993
Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women.
    Scandinavian journal of infectious diseases, 1997, Volume: 29, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis; Tobramycin

1997
[Cost savings by disinfection for prevention of surgical wound dehiscence after gastrectomy].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1997, Volume: 68, Issue:4

    Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Cefotaxime; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Gastrectomy; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Stomach Neoplasms; Surgical Wound Dehiscence; Surgical Wound Infection; Survival Rate; Tobramycin; Vancomycin

1997
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
    Annals of hematology, 2001, Volume: 80, Issue:2

    Topics: Adult; Aged; Cefotaxime; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Time Factors; Tobramycin

2001
Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial.
    The British journal of surgery, 2012, Volume: 99, Issue:2

    Topics: Administration, Oral; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Decontamination; Digestive System Diseases; Drug Combinations; Female; Hospital Mortality; Humans; Infusions, Intravenous; Intubation, Gastrointestinal; Length of Stay; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Respiration, Artificial; Tobramycin

2012
Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival.
    American journal of respiratory and critical care medicine, 2013, Jul-01, Volume: 188, Issue:1

    Topics: Administration, Intravenous; Aged; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cluster Analysis; Colistin; Critical Care; Cross Infection; Cross-Over Studies; Decontamination; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Tract; Hospital Mortality; Humans; Intensive Care Units; Intubation, Gastrointestinal; Male; Middle Aged; Netherlands; Odds Ratio; Oropharynx; Primary Prevention; Survival Analysis; Tobramycin; Treatment Outcome

2013

Other Studies

99 other study(ies) available for tobramycin and cefotaxime

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal

2007
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests

2007
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome

2007
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2007
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins

2007
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid

2007
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States

2008
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin

2008
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
VIM-15 and VIM-16, two new VIM-2-like metallo-beta-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Amino Acid Substitution; Bacterial Proteins; beta-Lactamases; Bulgaria; Catalysis; Germany; Hydrolysis; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA

2008
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins

2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids

2008
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial

2008
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia

2009
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence

2009
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Clinical Trials, Phase III as Topic; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Proteus mirabilis; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline

2009
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping

2009
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA

2009
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Ceftriaxone; Clindamycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections

2009
Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetyltransferases; beta-Lactamases; Ciprofloxacin; Conjugation, Genetic; Enterobacteriaceae; Microbial Sensitivity Tests; Plasmids

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom

2009
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial

2010
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors

2010
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Synthesis and antimicrobial profile of N-substituted imidazolium oximes and their monoquaternary salts against multidrug resistant bacteria.
    Bioorganic & medicinal chemistry, 2013, Dec-01, Volume: 21, Issue:23

    Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Multiple; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imidazoles; Microbial Sensitivity Tests; Mycoses; Oximes

2013
[Experiences with triple antibiotic combination in neonatal infection].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1992, Volume: 140, Issue:9

    Topics: Azlocillin; Bacteriological Techniques; Cefotaxime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Staphylococcal Infections; Streptococcal Infections; Streptococcus agalactiae; Tobramycin

1992
Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues.
    The Journal of infectious diseases, 1992, Volume: 165, Issue:4

    Topics: Abscess; Aerobiosis; Amikacin; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Drug Synergism; Enterobacteriaceae; Escherichia coli; Humans; Hydrogen-Ion Concentration; Mice; Oxygen; Pseudomonas aeruginosa; Ticarcillin; Tobramycin

1992
Evaluation of intraosseous vs intravenous antibiotic levels in a porcine model.
    American journal of diseases of children (1960), 1991, Volume: 145, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bone Marrow; Cefotaxime; Chloramphenicol; Female; Infusions, Intravenous; Infusions, Parenteral; Male; Models, Biological; Prospective Studies; Swine; Tobramycin; Vancomycin

1991
Effect of ceftazidime, cefotaxime, and cefoperazone on serum tobramycin concentrations.
    American journal of hospital pharmacy, 1991, Volume: 48, Issue:3

    Topics: Cefoperazone; Cefotaxime; Ceftazidime; Drug Interactions; Humans; Tobramycin

1991
Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia.
    Pediatric hematology and oncology, 1990, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Piperacillin; Retrospective Studies; Sepsis; Ticarcillin; Tobramycin

1990
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
    Der Anaesthesist, 1989, Volume: 38, Issue:5

    Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin

1989
Role of parenteral antibiotherapy in gastrointestinal tract flora suppression. A study in children treated with high-dose chemotherapy and autologous bone marrow transplantation.
    Bone marrow transplantation, 1989, Volume: 4, Issue:4

    Topics: Adolescent; Agranulocytosis; Bone Marrow Transplantation; Cefotaxime; Child; Child, Preschool; Digestive System; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Gentamicins; Gram-Positive Bacteria; Humans; Infusions, Parenteral; Male; Mezlocillin; Moxalactam; Sulfamethizole; Suppression, Genetic; Tobramycin; Transplantation, Autologous; Trimethoprim

1989
[Enterobacter cloacae infection and marked hypophosphatemia in a patient on hemodialysis].
    Medicina clinica, 1989, Feb-04, Volume: 92, Issue:4

    Topics: Administration, Oral; Cefotaxime; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Phosphates; Renal Dialysis; Tobramycin

1989
[Frequency of colonization and pneumonia and development of resistance in long-term ventilated intensive-care patients subjected to selective decontamination of the digestive tract].
    Der Anaesthesist, 1989, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Bacteria; Cefotaxime; Colistin; Critical Care; Digestive System; Female; Humans; Male; Middle Aged; Oropharynx; Pneumonia; Respiration, Artificial; Time Factors; Tobramycin

1989
Investigation of the immune status of mice during and following selective decontamination of the digestive tract.
    Epidemiology and infection, 1989, Volume: 103, Issue:2

    Topics: Amphotericin B; Animals; Antibody Formation; Bacitracin; Cefotaxime; Colistin; Digestive System; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Hypersensitivity, Delayed; Immunity, Cellular; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Random Allocation; Streptomycin; Tobramycin

1989
Urinary alanine-aminopeptidase (AAP) excretion in patients with urinary tract infection treated with ceftazidime (CAZ) or cefotaxime (CTX) plus tobramycin (TOB).
    International urology and nephrology, 1988, Volume: 20, Issue:5

    Topics: Adult; Aminopeptidases; CD13 Antigens; Cefotaxime; Ceftazidime; Clinical Enzyme Tests; Creatinine; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Kidney Function Tests; Male; Tobramycin; Urinary Tract Infections

1988
Comparative in vitro activity of lomefloxacin and other antimicrobials against 597 microorganisms causing bacteremia.
    Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Enoxacin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Norfloxacin; Quinolones; Sepsis; Tobramycin

1988
Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Adult; Cefotaxime; Chromatography, High Pressure Liquid; Drug Interactions; Enterobacter; Enterobacteriaceae; Female; Humans; Kinetics; Klebsiella; Listeria monocytogenes; Male; Pseudomonas; Serratia marcescens; Tobramycin

1986
Comparative evaluation of the diffusion of tobramycin and cefotaxime out of antibiotic-impregnated polymethylmethacrylate beads.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 1988, Volume: 6, Issue:2

    Topics: Anti-Bacterial Agents; Cefotaxime; Diffusion; Escherichia coli; Klebsiella; Methylmethacrylates; Microbial Sensitivity Tests; Osteomyelitis; Postoperative Complications; Time Factors; Tobramycin

1988
Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
    Drugs, 1988, Volume: 35 Suppl 2

    Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Neutropenia; Tobramycin; Vancomycin

1988
Cefotaxime combined with selective decontamination in long term intensive care unit patients. Virtual absence of emergence of resistance.
    Drugs, 1988, Volume: 35 Suppl 2

    Topics: Administration, Oral; Bacterial Infections; Cefotaxime; Colistin; Critical Care; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Infusions, Intravenous; Male; Time Factors; Tobramycin

1988
Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Drugs under experimental and clinical research, 1986, Volume: 12, Issue:4

    Topics: Amikacin; Cefotaxime; Cefotiam; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin

1986
Optimal conditions for injection of tobramycin and cefmenoxime into burn patients.
    Burns, including thermal injury, 1987, Volume: 13, Issue:4

    Topics: Adult; Aged; Bacterial Infections; Burns; Cefmenoxime; Cefotaxime; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Tobramycin

1987
The in-vitro activity and beta-lactamase stability of carumonam.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Culture Media; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Piperacillin; Tobramycin

1986
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:6

    Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Piperacillin; Thienamycins; Tobramycin

1986
[Granulocyte function modified by antibiotics].
    Beitrage zu Infusionstherapie und klinische Ernahrung, 1986, Volume: 15

    Topics: Anti-Bacterial Agents; Cefotaxime; Dose-Response Relationship, Drug; Doxycycline; Granulocytes; Humans; Luminescent Measurements; Neutrophils; Phagocytosis; Thienamycins; Tobramycin

1986
Recent advances in the control of infection in patients with thoracic injury.
    Injury, 1986, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Middle Aged; Thoracic Injuries; Tobramycin

1986
[In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Pathologie-biologie, 1985, Volume: 33, Issue:5 Pt 2

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin

1985
Cefotaxime and nafcillin-tobramycin.
    Annals of internal medicine, 1985, Volume: 102, Issue:2

    Topics: Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Nafcillin; Tobramycin

1985
[Endolymphatic therapy in the combined treatment of patients with respiratory diseases].
    Terapevticheskii arkhiv, 1985, Volume: 57, Issue:3

    Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bronchitis; Cefotaxime; Cefuroxime; Evaluation Studies as Topic; Female; Humans; Injections, Intralymphatic; Lung Abscess; Male; Middle Aged; Pneumonia; Respiratory Tract Diseases; Tobramycin

1985
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
    Journal of the Oslo city hospitals, 1984, Volume: 34, Issue:5

    Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin

1984
Ceftriaxone for meningitis, due to Escherichia coli, which developed during tobramycin therapy.
    The New Zealand medical journal, 1984, Jul-25, Volume: 97, Issue:760

    Topics: Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Meningitis; Middle Aged; Tobramycin

1984
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
    Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology, 1984, Volume: 257, Issue:3

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin

1984
Activities of two aminoglycosides and five newer beta-lactam antibiotics: safer alternatives to aminoglycosides?
    Current medical research and opinion, 1984, Volume: 9, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Humans; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Tobramycin

1984
Sensitivity testing and synergy.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6 Suppl A

    Topics: Azlocillin; Bacteria; Cefotaxime; Cephalosporins; Culture Media; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Tobramycin

1980
[Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
    Die Medizinische Welt, 1980, Aug-29, Volume: 31, Issue:35

    Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

1980
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
    Antimicrobial agents and chemotherapy, 1980, Volume: 17, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin

1980
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin

1980
In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 8, Issue:3

    Topics: Amikacin; Aminoglycosides; Cefotaxime; Cefotiam; Drug Interactions; Enterobacteriaceae; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Netilmicin; Proteus; Staphylococcus; Tobramycin

1981
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin

1981
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1981, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin

1981
Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefotaxime; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Sepsis; Tobramycin

1982
The efficacy of ceftizoxime in treating infections due to organisms resistant to other antibiotics.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Bacterial Infections; Carbenicillin; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalothin; Humans; Penicillin Resistance; Tobramycin

1982
Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections

1982
Synergism of ceftizoxime and tobramycin for Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1982, Volume: 10 Suppl C

    Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftizoxime; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Urinary Tract Infections

1982
Protocol for the study of drug interferences in laboratory tests: cefotaxime interference in 24 clinical tests.
    Clinical chemistry, 1983, Volume: 29, Issue:10

    Topics: Blood Chemical Analysis; Cefotaxime; False Positive Reactions; Female; Gentamicins; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Pregnancy; Probability; Tobramycin

1983
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Chemotherapy, 1983, Volume: 29, Issue:5

    Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin

1983
In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:2

    Topics: Amikacin; Cefotaxime; Ceftriaxone; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin

1983
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
    British medical journal (Clinical research ed.), 1983, Dec-03, Volume: 287, Issue:6406

    Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin

1983
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
    European journal of clinical microbiology, 1983, Volume: 2, Issue:5

    Topics: Amikacin; Animals; Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Leukopenia; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1983
A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract.
    Acta anaesthesiologica Belgica, 1983, Volume: 34, Issue:3

    Topics: Anti-Bacterial Agents; Cefotaxime; Cross Infection; Digestive System; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Intensive Care Units; Polymyxins; Respiratory Tract Infections; Sepsis; Tobramycin

1983
Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
    Antimicrobial agents and chemotherapy, 1983, Volume: 24, Issue:6

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Streptococcus; Time Factors; Tobramycin

1983
In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas; Quinolines; Staphylococcus; Tobramycin

1984
Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis.
    Annals of surgery, 1995, Volume: 222, Issue:2

    Topics: Acute Disease; Administration, Oral; Amphotericin B; Animals; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Cecal Diseases; Cefotaxime; Colistin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Injections, Intravenous; Kidney Diseases; Male; Necrosis; Pancreas; Pancreatic Diseases; Pancreatitis; Rats; Rats, Sprague-Dawley; Survival Rate; Tobramycin

1995
Opacification of Middlebrook agar as an aid in distinguishing Nocardia farcinica within the Nocardia asteroides complex.
    Journal of clinical microbiology, 1994, Volume: 32, Issue:9

    Topics: Actinomycetales; Agar; Animals; Australia; Bacteriological Techniques; Cefotaxime; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Fish Diseases; Fishes; Humans; Nephelometry and Turbidimetry; Nocardia; Nocardia asteroides; Nocardia Infections; Species Specificity; Tobramycin

1994
Antibiotic-induced release of endotoxin from bacteria in vitro.
    Journal of medical microbiology, 1994, Volume: 40, Issue:1

    Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Endotoxins; Enterobacter cloacae; Escherichia coli; Humans; Limulus Test; Lipopolysaccharides; Microscopy, Electron, Scanning; Piperacillin; Silver Staining; Tobramycin

1994
[Infectious endocarditis caused by Escherichi coli].
    Enfermedades infecciosas y microbiologia clinica, 1996, Volume: 14, Issue:8

    Topics: Adult; Bacteremia; Cefotaxime; Cloxacillin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; HIV Infections; Humans; Injections, Intravenous; Male; Substance Abuse, Intravenous; Tobramycin; Urinary Tract Infections

1996
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
    American clinical laboratory, 1995, Volume: 14, Issue:7

    Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin

1995
In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:5

    Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Decontamination; Digestive System; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymyxins; Tobramycin

2000
[Pacemaker-cable endocarditis and spondylodiscitis caused by Citrobacter koseri. Conservative treatment].
    Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:1

    Topics: Aged; Bacteremia; Cefotaxime; Citrobacter; Discitis; Drug Therapy, Combination; Electrodes, Implanted; Endocarditis, Bacterial; Enterobacteriaceae Infections; Equipment Contamination; Humans; Imipenem; Lumbar Vertebrae; Male; Pacemaker, Artificial; Sacrum; Tobramycin

2001
Molecular epidemiology of antibiotic-resistant Gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
    Pediatrics, 2002, Volume: 109, Issue:6

    Topics: Amoxicillin; Cefotaxime; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Molecular Epidemiology; Penicillins; Risk Factors; Tobramycin

2002
Rapidly fatal acute bacterial myocarditis in a nonneutropenic child with acute lymphoblastic leukemia in remission.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8

    Topics: Acute Disease; Agammaglobulinemia; Antineoplastic Combined Chemotherapy Protocols; Cefotaxime; Child; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Myocarditis; Oxacillin; Pericarditis; Pleurisy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Shoulder Pain; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2002
Spontaneous haemophilus influenzae type B meningoventriculitis with intraventricular debris.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:4

    Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefotaxime; Cerebrospinal Fluid; Drug Therapy, Combination; Follow-Up Studies; Haemophilus influenzae type b; Humans; Injections, Intravenous; Lateral Ventricles; Latex Fixation Tests; Magnetic Resonance Imaging; Male; Meningitis, Haemophilus; Middle Aged; Tobramycin; Tomography, X-Ray Computed

2005
[Extensive Fournier gangrene. A dermatologic emergency].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2006, Volume: 57, Issue:3

    Topics: Adult; Cefotaxime; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Follow-Up Studies; Fournier Gangrene; Genital Diseases, Male; Humans; Male; Metronidazole; Necrosis; Penile Diseases; Scrotum; Skin; Streptococcal Infections; Streptococcus pyogenes; Tobramycin

2006
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult

2011
Coincident diagnosis of a pulmonary abscess and ascaris lumbricoides infection: a possible causal connection?
    Klinische Padiatrie, 2012, Volume: 224, Issue:7

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antinematodal Agents; Ascariasis; Ascaris lumbricoides; Cefixime; Cefotaxime; Child; Comorbidity; Drug Therapy, Combination; Follow-Up Studies; Humans; Infusions, Intravenous; Lung Abscess; Male; Mebendazole; Tobramycin; Tomography, X-Ray Computed

2012
Haemophilus influenzae: a forgotten cause of neonatal sepsis?
    Acta clinica Belgica, 2015, Volume: 70, Issue:3

    Topics: Anti-Bacterial Agents; Cefotaxime; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Microbial Sensitivity Tests; Sepsis; Serotyping; Time Factors; Tobramycin; Treatment Outcome

2015
MBT-ASTRA: A suitable tool for fast antibiotic susceptibility testing?
    Methods (San Diego, Calif.), 2016, 07-15, Volume: 104

    Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tobramycin

2016
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
    Anaesthesia, critical care & pain medicine, 2019, Volume: 38, Issue:5

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin

2019
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
    Scientific reports, 2023, 01-09, Volume: 13, Issue:1

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing

2023